Depresión

Black cohosh has documented scientific evidence for reducing uterine fibroid size in postmenopausal women. A randomized double-blind parallel-controlled study in 62 Chinese women found that 40 mg/day isopropanolic Cimicifuga racemosa extract reduced total myoma volume by 30.3% over 12 weeks, compared to a slight increase in the tibolone group. It has a long traditional history as a uterine stimulant used by Native American herbalists and midwives.

Black seed (Nigella sativa) has been identified as one of the key herbs with pharmacological evidence for uterine health in Persian medicine. A randomized double-blind clinical trial of 124 female students found topical Nigella sativa oil significantly reduced primary dysmenorrhea intensity versus olive oil placebo over three menstrual cycles. It is among the most frequently cited species in Persian Medicine uterine disorder literature.

Adlay hull extracts have been shown to relax uterine smooth muscle and relieve oxytocin/PG-induced contractions in both in vitro and in vivo models, supporting a role in dysmenorrhea. Coix also promotes uterine contraction at parturition in animal studies, and Coicis Semen has been studied in clinical trials for gynecological cancers.

Curcumin, the principal polyphenol from turmeric, has demonstrated anti-uterine fibroid and anti-endometriosis activity in multiple preclinical studies. It inhibits leiomyoma cell proliferation via PPARγ activation, arrests endometriosis by downregulating MMP-9, reduces estradiol production in endometriotic cells, and protects uterine myometrium from oxidative damage. Human clinical trials are still needed.

DIM has been studied in multiple RCTs for cervical intraepithelial neoplasia (CIN), a condition of uterine cervical cells. A Phase IIa multicenter RCT (n=78) showed intravaginal DIM significantly improved CIN I-II regression. In vitro research demonstrates DIM suppresses estrogen-driven proliferation and EMT in human endometrial cancer cells.

EGCG from green tea has demonstrated anti-uterine fibroid activity in both preclinical models and a human pilot RCT. A randomized controlled trial found that 800 mg/day EGCG over 4 months significantly reduced uterine fibroid volume and improved anemia and quality of life in premenopausal women compared to placebo.

Genistein, a soy isoflavone phytoestrogen, has demonstrated antiproliferative effects on uterine leiomyoma cells in vitro and has been studied for its repressive effects on estradiol-induced uterine leiomyoma cell proliferation. It acts via estrogen receptor modulation relevant to uterine fibroid pathology.

Green tea extract, primarily through its active catechin EGCG, has clinical RCT evidence for reducing uterine fibroid volume and improving fibroid-related symptoms. A 4-month randomized controlled pilot trial found 800 mg/day green tea extract (45% EGCG) significantly reduced total fibroid volume by ~32.6% versus placebo in premenopausal women.

Indole-3-Carbinol (I3C), found in cruciferous vegetables, has demonstrated anti-uterine fibroid activity in preclinical studies, inhibiting extracellular matrix expression in primary human uterine leiomyoma cells and modulating estrogen metabolism to favor less potent estrogen metabolites protective of uterine tissue.

Motherwort (Leonurus cardiaca/japonicus) has traditional and emerging scientific evidence for uterine health. A 2022 systematic review and meta-analysis of RCTs found motherwort injection may reduce uterine hemorrhage risk after induced abortion and restore endometrial thickness more effectively than oxytocin alone. Traditionally, it has been used as a uterine stimulant and emmenagogue in European and Chinese herbal medicine.

C. rotundus is used in TCM and Ayurveda as a primary herb for uterine health, including dysmenorrhea, amenorrhea, and abnormal uterine bleeding. TCM formulations containing C. rotundus have been validated for reducing uterine bleeding. Cell-based studies show inhibition of endometriotic cell adhesion.

Progesterone is essential for maintaining uterine health by preventing endometrial hyperplasia and cancer in estrogen-exposed women. It transforms the proliferative endometrium into a secretory state and is the primary protection against estrogen-driven endometrial pathology. This is a cornerstone of MHT prescribing and is supported by Level 1 evidence.

Quercetin has preclinical evidence for anti-uterine fibroid activity, demonstrating inhibition of extracellular matrix expression in primary human uterine leiomyoma cells in a 2020 study. It also has anti-inflammatory and anti-proliferative properties relevant to endometrial health.

Resveratrol has demonstrated anti-uterine fibroid activity in preclinical models. In vitro and in vivo studies show it inhibits leiomyoma cell proliferation, induces apoptosis, reduces extracellular matrix protein expression, and suppresses tumor growth in mouse xenograft models. It is included among the natural compounds under investigation for uterine fibroid management.

Saffron (Crocus sativus) has documented pharmacological effects on uterine smooth muscle, with evidence for both uterotonic and antispasmodic activity depending on its active constituents. In Persian traditional medicine, it has been used for dysmenorrhea and as an emmenagogue. Clinical studies show it can improve PMS symptoms and has cervical ripening effects at term.

Shepherd's purse exerts documented uterotonic and hemostatic effects on the uterus, supported by two RCTs demonstrating reduced postpartum hemorrhage and heavy menstrual bleeding. The EMA HMPC lists it as a traditional herbal medicinal product specifically for uterine bleeding. Bioactive peptides mimic oxytocin action on uterine smooth muscle.

Dipsacus asper has documented TCM use for uterine bleeding, threatened miscarriage, and uterine instability, and preclinical pharmacological studies have confirmed anti-uterine contraction activity. The 2020 comprehensive review on ScienceDirect lists 'anti-uterine contraction' as a confirmed in vitro and in vivo bioactivity. No human reproductive clinical trials have been conducted.

Turmeric (Curcuma longa) and its active compound curcumin have preclinical evidence supporting uterine health, specifically protection of the uterine myometrium against oxidative damage implicated in fibroid development, and anti-endometriotic activity in animal models. Turmeric also has traditional use in Indian Ayurvedic medicine for uterine and gynecological conditions.

Vitex agnus-castus (chasteberry) has robust clinical evidence for gynecological use, particularly for premenstrual syndrome, abnormal uterine bleeding, and luteal phase defects. Multiple RCTs and systematic reviews demonstrate its superiority over placebo for PMS. It modulates prolactin secretion and progesterone levels, supporting uterine cycle regulation.

Ashoka (Saraca asoca) is a cornerstone herb of Ayurvedic medicine for female reproductive health, primarily used as a uterine tonic for dysmenorrhea, leucorrhea, menorrhagia, and uterine disorders. ACS Omega (2023) confirmed its traditional use as a uterine tonic with pharmacological evidence of antimenorrhagic and antioxytocic activity in animal models.

Barberry has documented traditional use as a uterine stimulant and emmenagogue in herbal medicine, explaining its contraindication in pregnancy. This is a pharmacologically acknowledged property attributed to berberine's effects on smooth muscle.

Wild yam has been used historically as a uterine tonic, indicated for uterine cramping, ovarian pain, and reproductive system disorders. Its antispasmodic properties on uterine smooth muscle underpin this traditional use. No clinical trials exist for uterine health endpoints.

Dong Quai (Angelica sinensis) has been used in Traditional Chinese Medicine for over 2,000 years as a primary uterine tonic, prescribed for dysmenorrhea, amenorrhea, and menstrual irregularities. Its bioactive compound Z-ligustilide has shown uterine smooth muscle antispasmodic activity in animal studies. Clinical human evidence remains limited and mixed.

TCM documentation consistently records eucommia bark as supporting uterine health through its 'fetus-calming' and menstruation-regulating actions. Traditional indications include vaginal bleeding, threatened miscarriage, and uterine instability. Eucommia is identified as a source of SERMs which may have uterine tissue interactions. No human clinical data exist.

Gravel root was used by Native American tribes and Eclectic physicians as a uterine tonic and partus preparator—to tone the uterus and prepare for labor. Traditional herbalists also noted it for chronic uterine disease. No clinical evidence exists.

A. vulgaris has a centuries-long tradition of use for uterine health in TCM, European, and Hindu medicine, including for threatened miscarriage, uterine bleeding, and uterine positioning (via moxibustion). Moxibustion RCTs for breech presentation demonstrate the most direct human clinical evidence of uterine-relevant effects. The plant's estrogenic and uterotonic pharmacology provides mechanistic support.

Myrrh is used as an emmenagogue and uterine tonic in TCM, Ayurveda, and Western herbal traditions. In TCM, it is classified as moving stagnant blood from the uterus. A clinical case report noted reduction of an ovarian cyst with myrrh tincture.

Parsley has extensive traditional use as a uterine tonic, stimulant, and emmenagogue. Its volatile oils apiol and myristicin stimulate uterine contractions, and recent animal studies indicate parsley extracts have estrogenic effects, increasing uterine protein and serum estradiol levels. Clinical evidence in women is lacking.

Paeonia lactiflora has been used for gynecological conditions including dysmenorrhea, uterine cramps, and menstrual irregularity for over 1,200 years. Preclinical evidence documents antispasmodic effects on uterine smooth muscle, and research in cell and animal models supports roles in endometrial receptivity and lesion reduction.

Red raspberry leaf is one of the most historically recognized herbal uterine tonics, used by midwives to strengthen and tone the uterus in preparation for labor and to prevent excessive postpartum bleeding. Animal studies show biophysical effects on uterine smooth muscle, though human clinical trials show no statistically significant benefit for labor outcomes. Its use is primarily traditional.

Red clover (Trifolium pratense) contains isoflavones that bind estrogen receptor sites and modulate estrogenic activity, providing traditional use as a uterine tonic and fertility herb. Its phytoestrogens are used to prepare the uterus for pregnancy and to manage menopausal symptoms. Clinical evidence focuses more on menopausal hot flashes than direct uterine structural effects.

Smartweed has documented traditional use in regulating uterine function, including as an emmenagogue and in managing uterine bleeding. Antifertility/contraceptive effects have also been documented in animal models.

Squawvine has one of its most deeply rooted traditional applications as a uterine tonic. Native American women, particularly among the Cherokee, Iroquois, Delaware, and other Eastern Woodland tribes, used it to strengthen the uterus and prepare for childbirth. Eclectic physicians of the 19th century adopted it as a 'partus preparator.' No controlled clinical trials have validated these uses.

Wild yam (Dioscorea villosa) is a widely used traditional uterine antispasmodic herb employed by herbalists and midwives for dysmenorrhea, uterine cramping, threatened miscarriage, and chronic pelvic pain. Its constituent diosgenin is a steroid precursor used industrially in hormone synthesis. No contemporary clinical trials have validated its direct uterine muscle effects in humans.